MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases
These compelling results support advancing the development of nintedanib DPI for patients living with IPF, a chronic and progressive fibrotic lung disease with limited treatment options,” said Michael ...
verywellhealth4d
Mycobacterium Avium Complex (MAC) Infection and Lung Effects
Exposure to mycobacterium avium complex (MAC) infection happens because of contaminated water or soil. Learn who gets severe ...
DWP urges people to claim these two benefits 'together' for free £1,130
DWP has confirmed that millions on benefits who claim Universal Credit and PIP could benefit from the payments.
Universal Credit DWP PIP claimants with a disability could get £1,130 a month
More than seven million people in England, Scotland and Wales are recorded as receiving support through the DWP's Universal ...
pulmonaryfibrosisnews6d
Now you know: Updates from my journey living with IPF
Living with IPF is never dull, says columnist Sam Kirton, who shares some updates on topics he's discussed in recent columns.
Pharmabiz6d
MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases
MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases: Danbury, Connecticut Tuesday, November 5, 2024, 16:00 Hrs [IST] MannKind Corporation, a company ...